Alex Kentsis, MD, PhD

I am a pediatric oncologist who treats children and young adults with leukemias and refractory solid tumors. In particular, I am interested in developing treatments that maximize the success of currently available therapies and devising new therapies that are precise, curative, and safe.

My research takes advantage of modern technologies to improve our understanding of the biologic causes of blood and solid tumors. Together with colleagues, I have made discoveries about new therapeutic targets in cancer cells, mechanisms by which cancer cells can evade new treatments, and improved strategies to overcome treatment resistance. I am a member of the Children's Oncology Group, where I help to devise national clinical trials of improved treatments that leverage these advances. This work has been recognized by the Research Award from the Society of Pediatric Research (2009), Investigator Award from the Alliance for Clinical Trials in Oncology (2012), the Investigator Award from the American Society for Pediatric Hematology/Oncology (2013), and the Scholar Award from the American Society of Hematology (2014). 

Appointments for New Patients
Clinical Expertise

Leukemias and Refractory Tumors in Children and Young Adults

Languages Spoken
English; Russian

MD, PhD, Mount Sinai School of Medicine


Boston Children’s Hospital


Boston Children’s Hospital; Dana-Farber Cancer Institute

Board Certifications

Pediatrics; Pediatric Hematology/Oncology

See My Colleagues in:
Publications by Alex Kentsis
Visit PubMed for full listing of Alex Kentsis journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.
View Alex Kentsis's laboratory research.